chronic kidney disease Archives - Express Pharma

Bayer, Sun Pharma sign marketing and distribution pact for second brand of Finerenone

Sun Pharma, Zydus sign licensing pact to co-market Desidustat for CKD treatment in India

Pari CKDu Foundation, Tanker Foundation and Centaur Pharma join hands to fight CKDu

Japan approves Forxiga to treat chronic kidney disease in patients with and without type-II diabetes

Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes

Lupin gets US FDA approval for Sevelamer Hydrochloride Tablets

JBCPL forays into nephrology segment in India with new division called RENOVA

AstraZeneca gets US FDA nod for FARXIGA to treat chronic kidney disease

Lupin gets USFDA approval for Sevelamer Carbonate Tablets

Dr Reddy’s launches Cinacalcet Tablets in US